XML 50 R40.htm IDEA: XBRL DOCUMENT v2.4.0.6
Goodwill And Other Intangible Assets (Narrative) (Details) (USD $)
In Millions, unless otherwise specified
12 Months Ended 3 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Sep. 30, 2011
Bioniche Pharma Holdings Limited [Member]
Business Acquisition [Line Items]        
Amortization expense $ 357.8 $ 290.3 $ 276.8  
Expected amortization expense, 2012 336      
Expected amortization expense, 2013 330      
Expected amortization expense, 2014 322      
Expected amortization expense, 2015 300.0      
Expected amortization expense, 2016 232      
Impairment charge       16.2
Acquired in-process research and development assets reclassified to product rights and licenses $ 4.3